| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_129e393582e6bdf4029baf2206522f45 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5585 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5585 |
| filingDate |
1998-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cdb344a62e20172339264d2c28f6f41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5c7b68bc553510b627ccf85d8f7fe06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c66ef19b084f6518ad94cd0b4dc7e7df |
| publicationDate |
1999-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0925788-A1 |
| titleOfInvention |
Drugs for relieving diabetic vascular lesion |
| abstract |
The present invention provides a diabetic angiopathynimproving agent comprising a prostaglandin I derivative suchnas beraprost as an active component, and a method ofnpreventing diabetic angiopathy by using the improving agent.nThis medicine exhibits excellent effects as a diabeticnangiopathy inhibiting agent in both oral administration andnparenteral administration. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03020283-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03020283-A3 |
| priorityDate |
1997-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |